OncoDecipher
About
Technology stack
detected 2026-05-26No comments yet. Be the first to share your take.
What does OncoDecipher do?
OncoDecipher is a life sciences company focused on developing novel diagnostic tools for cancer. Their proprietary technology analyzes silent mutations within cancer genomes to predict a patient's specific cancer type and their probability of survival, aiming to improve personalized treatment strategies.
How much funding has OncoDecipher raised?
OncoDecipher has raised a total of $1M in funding. The most recent round on record is Seed.
Where is OncoDecipher headquartered?
OncoDecipher is headquartered in Cambridge, United States.
When was OncoDecipher founded?
OncoDecipher was founded in 2015.
What industry does OncoDecipher operate in?
OncoDecipher operates in Life Sciences, Cancer, Oncology, Mutation, Genomics, Biotech.
What is OncoDecipher's current status?
OncoDecipher's current operating status is: Inactive.
What is OncoDecipher's revenue?
StartupHub estimates OncoDecipher's annual revenue at $275K (range $68K to $425K, 27% confidence), based on comparable companies in the sector.
What is OncoDecipher's valuation?
StartupHub estimates OncoDecipher's effective valuation at $3.6M (range $2.5M to $6.0M, 10% confidence), based on comparable companies in the sector.